Recurrent Anger Outbursts Linked To Chronic Inflammation

According to a study conducted by Dr. Stephen H Boyle of Duke University Medical Center in Durham, North Carolina, recurrent blow-ups like road rages may be linked to have a biological basis. Display of hostile outbursts characterizes a mental illness known as Intermittent Explosive Disorder which also shows signs of inflammation, according to a blood test analysis by researchers.

CNN health explains Intermittent Explosive Disorder (IED) as a behavioral disorder characterized by extreme expressions of anger. While ‘Inflammation is the body’s effort to prevent the body against external or internal pathogens. When the body faces a danger, it reacts by inflating the particular body part, and begins the healing process.’ [To read more on inflammation:Inflammation: An Innate Immune System]

The people who have diagnosed with the condition suffer from episodes of out of proportion aggression. Whenever anger is triggered, they completely lose control on minor things, hurt people, throw belongings and break property.

Research indicates that elevated level of C-reactive protein and interleukin-6, which indicates inflammation in blood, are said to be linked with impulsive and aggressive behavior in people. There is a cause and effect relationship between inflammation and IED.

Presently, medication and behavioral therapy are used for treating IED, although these methods are less effective. It’s important for the people suffering from this condition to seek treatment, rather than expecting their family and loved ones to live with their hostile and aggressive behavior.  Moreover, inflammation also put people at risk for other medical complications such as heart attack, arthritis and stroke.

Bentham Science Publishers is one of the leading STM publishing companies. It publishes 116 online and print journals, 150 plus open access journals, and related print/online book series. One of the latest journals is “Inflammation & Allergy - Drug Targets”. The journal aims to cater to the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continues to grow, this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.